| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MOLIMM.2009.02.030 |
| P8608 | Fatcat ID | release_awmp2fyoqnh5npexdtjzvrvfka |
| P698 | PubMed publication ID | 19356803 |
| P50 | author | Nikolaus Thuille | Q43291712 |
| Natascha Hermann-Kleiter | Q120598795 | ||
| P2093 | author name string | Gottfried Baier | |
| Jianping Li | |||
| Thomas Gruber | |||
| Michael Leitges | |||
| Juergen Wagner | |||
| Christa Pfeifhofer-Obermair | |||
| Monika Baudler | |||
| Christina Lutz-Nicoladoni | |||
| Thomas Letschka | |||
| Johannes Barsig | |||
| Barbara Metzler | |||
| Barbara Nüsslein-Hildesheim | |||
| P433 | issue | 10 | |
| P304 | page(s) | 2071-2079 | |
| P577 | publication date | 2009-04-07 | |
| P1433 | published in | Molecular Immunology | Q6895954 |
| P1476 | title | PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo | |
| P478 | volume | 46 |
| Q37215114 | Doubling down on PKC benefits allogeneic BMT. |
| Q36978029 | Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes |
| Q42071747 | From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes |
| Q34319398 | IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan |
| Q46029282 | Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation. |
| Q41975118 | Involvement of distinct PKC gene products in T cell functions |
| Q39617623 | Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation |
| Q42287222 | PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors |
| Q37898306 | PKC-θ function at the immunological synapse: prospects for therapeutic targeting |
| Q27320965 | PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes |
| Q54525535 | PKCθ: a new target for selective immunosuppression. |
| Q39721783 | PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle |
| Q37215167 | Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice |
| Q38217280 | Protein kinase C inhibitors for immune disorders |
| Q21131217 | Protein kinase C signaling and cell cycle regulation |
| Q36377731 | Protein kinase C theta is dispensable for suppression mediated by CD25+CD4+ regulatory T cells. |
| Q27334727 | Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells |
| Q54309549 | Protein kinase Cθ: the pleiotropic T-cell signalling intermediate. |
| Q47273020 | Protein kinase D2: a versatile player in cancer biology |
| Q34144420 | TCR-induced Akt serine 473 phosphorylation is regulated by protein kinase C-alpha |
| Q42275078 | Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential |
| Q36141554 | Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators |
| Q43031049 | The kinase PKCα selectively upregulates interleukin-17A during Th17 cell immune responses |
| Q37520009 | The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression |
| Q26751959 | Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies |
| Q28512344 | Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells |
Search more.